Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency

Clinical Immunology

Volumn 141, Issue 1, 2011, Pages 58-66

  Farkas, Henriette ^a   Csuka, Dorottya ^a   Gács, Judit ^a   Czaller, Ibolya ^a   Zotter, Zsuzsanna ^a   Füst, George ^a   Varga, Lilian ^a   Gergely, Péter ^b  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Autoantibodies; C1 inhibitor deficiency; Hereditary angioedema; Immunoregulatory disease; Prevalence; Screening

Indexed keywords

CARDIOLIPIN ANTIBODY; COMPLEMENT COMPONENT C1S INHIBITOR;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; IMMUNOPATHOLOGY; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PREVALENCE; PRIORITY JOURNAL;

ADULT; ANGIOEDEMA; ANTIBODIES, ANTICARDIOLIPIN; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; CAUSALITY; CELIAC DISEASE; COMPLEMENT C1 INHIBITOR PROTEIN; FEMALE; HEREDITARY ANGIOEDEMA TYPES I AND II; HUMANS; IGA DEFICIENCY; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 80053130910     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2011.05.004     Document Type: Article

References (45)

1. Bowen T., Cicardi M., Farkas H., Bork K., Longhurst H.J., Zuraw B., et al. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin. Immunol. Jul 28 2010, 6(1):24.
2. Cugno M., Zanichelli A., Foieni F., Caccia S., Cicardi M. C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. Trends Mol. Med. 2009, 15:69-78.
3. Lhotta K., Wurzner R., Rumpelt H.J., Eder P., Mayer G. Membranous nephropathy in a patient with hereditary complete complement C4 deficiency. Nephrol. Dial. Transplant. 2004, 19:990-993.
4. Hussain A., Prasad K.S., Bhattacharyya D., El-Bouri K. C2 deficiency primary meningococcal arthritis of the elbow by Neisseria meningitidis serogroup Y in a 12-year old girl. Infection 2007, 35:287-288.
5. Pickering M.C., Botto M., Taylor P.R., Lachmann P.J., Walport M.J. Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv. Immunol. 2000, 76:227-324.
6. Bussone G., Mouthon L. Autoimmune manifestations in primary immune deficiencies. Autoimmun. Rev. 2009, 8:332-336.
7. Brickman C.M., Tsokos G.C., Balow J.E., Lawley T.J., Santaella M., Hammer C.H., et al. Immunoregulatory disorders associated with hereditary angioedema. I. Clinical manifestations of autoimmune disease. J. Allergy Clin. Immunol. 1986, 77:749-757.
8. Brickman C.M., Tsokos G.C., Chused T.M., Balow J.E., Lawley T.J., Santaella M., et al. Immunoregulatory disorders associated with hereditary angioedema. II. Serologic and cellular abnormalities. J. Allergy Clin. Immunol. 1986, 77:758-767.
9. Kohler P.F., Percy J., Campion W.M., Smyth C.J. Hereditary angioedema and "familial" lupus erythematosus in identical twin boys. Am. J. Med. 1974, 56:406-411.
10. Koide M., Shirahama S., Tokura Y., Takigawa M., Hayakawa M., Furukawa F. Lupus erythematosus associated with C1 inhibitor deficiency. J. Dermatol. 2002, 29:503-507.
11. Hory B., Panouse-Perrin J., Saint-Hyllier Y., Perot C. Hereditary deficiency of C1 esterase inhibitor. Lupus and glomerulonephritis. Rev. Med. Interne 1983, 4:57-63.
12. Shiraishi S., Nara Y., Watanabe Y., Matsuda K., Miki Y. C1 inhibitor deficiency simulating systemic lupus erythematosus. Br. J. Dermatol. 1982, 106:455-460.
13. Suzuki Y., Nihei H., Mimura N., Hara M. A case of hereditary angioneurotic edema associated with systemic lupus erythematosus. Jpn. J. Med. 1986, 25:281-287.
14. Hory B., Blanc D., Boillot A., Panouse-Perrin J. Guillain-Barre syndrome following danazol and corticosteroid therapy for hereditary angioedema. Am. J. Med. 1985, 79:111-114.
15. Kim S.H., Lee B.J., Chang Y.S., Kim Y.K., Cho S.H., Min K.U., et al. A case of hereditary angioedema associated with idiopathic hypoparathyroidism. Korean J. Intern. Med. 2001, 16:281-283.
16. Srinivasan J., Beck P. IgA nephropathy in hereditary angioedema. Postgrad. Med. J. 1993, 69:95-99.
17. Agostoni A., Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore) 1992, 71:206-215.
18. Sturfelt G., Rydgren L., Truedsson L., Alm P., Sjoholm A.G. C1 inhibitor deficiency in a patient with rheumatoid arthritis-increased risk of adverse effects of penicillamine?. J. Rheumatol. 1996, 23:378-381.
19. Csuka D., Kelemen Z., Czaller I., Molnar K., Fust G., Varga L., et al. Association of celiac disease and hereditary angioedema due to C1-inhibitor deficiency. Screening patients with hereditary angioedema for celiac disease: is it worth the effort?. Eur. J. Gastroenterol. Hepatol. 2011, 23:238-244.
20. Farkas H., Varga L. The Hungarian HAE experience. Transfus. Apher. Sci. 2003, 29:229-233.
21. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br. J. Haematol. 2003, 121:749-757.
22. Richey R., Howdle P., Shaw E., Stokes T. Recognition and assessment of coeliac disease in children and adults: summary of NICE guidance. BMJ 2009, 338:b1684.
23. Hallek M., Cheson B.D., Catovsky D., Caligaris-Cappio F., Dighiero G., Dohner H., et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008, 111:5446-5456.
24. Lichtenstein G.R., Hanauer S.B., Sandborn W.J. Management of Crohn's disease in adults. Am. J. Gastroenterol. 2009, 104:465-483. [quiz 4, 84].
25. Singer P.A., Cooper D.S., Levy E.G., Ladenson P.W., Braverman L.E., Daniels G., et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. JAMA 1995, 273:808-812.
26. Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies. Clin. Exp. Immunol. 1999, 118(Suppl 1):1-28.
27. Newsome G. Guidelines for the management of rheumatoid arthritis: 2002 update. J. Am. Acad. Nurse Pract. 2002, 14:432-437.
28. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 2002, 61:554-558.
29. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997, 40:1725.
30. Farkas H., Gyeney L., Nemesanszky E., Kaldi G., Kukan F., Masszi I., et al. Coincidence of hereditary angioedema (HAE) with Crohn's disease. Immunol. Invest. 1999, 28:43-53.
31. Korponay-Szabo I.R., Kovacs J.B., Czinner A., Goracz G., Vamos A., Szabo T. High prevalence of silent celiac disease in preschool children screened with IgA/IgG antiendomysium antibodies. J. Pediatr. Gastroenterol. Nutr. 1999, 28:26-30.
32. Korponay-Szabo I.R., Szabados K., Pusztai J., Uhrin K., Ludmany E., Nemes E., et al. Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study. BMJ 2007, 335:1244-1247.
33. Muhlemann M.F., Macrae K.D., Smith A.M., Beck P., Hine I., Hegde U., et al. Hereditary angioedema and thyroid autoimmunity. J. Clin. Pathol. 1987, 40:518-523.
34. Nielsen E.W., Gran J.T., Straume B., Mellbye O.J., Johansen H.T., Mollnes T.E. Hereditary angio-oedema: new clinical observations and autoimmune screening, complement and kallikrein-kinin analyses. J. Intern. Med. 1996, 239:119-130.
35. Tan E.M., Feltkamp T.E., Smolen J.S., Butcher B., Dawkins R., Fritzler M.J., et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum. 1997, 40:1601-1611.
36. Ghosh P., Dwivedi S., Naik S., Agarwal V., Verma A., Aggarwal A., et al. Antinuclear antibodies by indirect immunofluorescence: optimum screening dilution for diagnosis of systemic lupus erythematosus. Indian J. Med. Res. 2007, 126:34-38.
37. Marin G.G., Cardiel M.H., Cornejo H., Viveros M.E. Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases. J. Clin. Rheumatol. 2009, 15:325-329.
38. Arbuckle M.R., McClain M.T., Rubertone M.V., Scofield R.H., Dennis G.J., James J.A., et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 2003, 349:1526-1533.
39. Varga L., Biro A., Szeplaki G., Toth L., Horvath A., Fust G., et al. Anti-cholesterol antibody levels in hereditary angioedema. J. Cell. Mol. Med. 2007, 11:1377-1383.
40. Loos M., Borsos T., Rapp H.J. Activation of the first component of complement evidence for an internal activation step. J. Immunol. 1972, 108:683-688.
41. Ghebrehiwet B., Randazzo B.P., Kaplan A.P. Studies of complement autoactivatability in hereditary angioedema: direct relationship to functional C-1-INA and the effect of classical pathway activators. Clin. Immunol. Immunopathol. 1984, 32:101-110.
42. Windfuhr J.P., Alsenz J., Loos M. The critical concentration of C1-esterase inhibitor (C1-INH) in human serum preventing auto-activation of the first component of complement (C1). Mol. Immunol. 2005, 42:657-663.
43. Cugno M., Nuijens J., Hack E., Eerenberg A., Frangi D., Agostoni A., et al. Plasma levels of C1-inhibitor complexes and cleaved C1-inhibitor in patients with hereditary angioneurotic edema. J. Clin. Invest. 1990, 85:1215-1220.
44. Carroll M.C. The complement system in regulation of adaptive immunity. Nat. Immunol. 2004, 5:981-986.
45. Chien P., Pixley R.A., Stumpo L.G., Colman R.W., Schreiber A.D. Modulation of the human monocyte binding site for monomeric immunoglobulin G by activated Hageman factor. J. Clin. Invest. 1988, 82:1554-1559.